Pressure BioSciences to Participate in SCIEX Workshop on New
Innovations Towards Industrialized Proteomics at US HUPO Conference
SCIEX Seminar Will Focus on Using Industrialized Omics to
Perform Translational Research Needed to Enable Precision
Medicine
South Easton, MA -- March 14, 2016 -- InvestorsHub NewsWire --
Pressure BioSciences, Inc. (OTCQB:
PBIO) (PBI and the Company), a leader in the development and
sale of broadly enabling pressure cycling technology (PCT)-based
sample preparation solutions to the worldwide life sciences
industry, today announced that SCIEX, a global leader in life
science analytical technologies, will present and lead a precision
medicine workshop on New Innovations Towards Industrialized
Proteomics at the annual conference of the US Human Proteome
Organization (US HUPO). US HUPO is being held from March 13-16 in
Boston, MA. Representatives from SCIEX, Pressure BioSciences, Inc.,
and Advaita Bioinformatics will share insightful examples of how
SCIEX next-generation solutions are enabling life science
researchers to unlock the potential of their discoveries using
industrialized omics to enable precision medicine. The workshop
will showcase examples of how SCIEXs next-generation mass
spectrometry-based solutions, combined with PBIs PCT platform and
Advaitas iPathwayGuide, provide the ability to industrialize omics
research workflows.
Life science researchers who are striving to transition from
basic research to translational research will receive information
about providing sample to biology solutions, as well as on
accelerating and facilitating the biomarker research pipeline, from
discovery and validation to translation into biologically and
clinically relevant knowledge. The workshops seminars include:
Mark Cafazzo, Director of Academic Business at SCIEX. Mr.
Cafazzo will lead a practical discussion on new technologies for
enabling reproducible and biologically meaningful results from
proteomics experiments across very large sample cohorts in an
effort to Industrialize Proteomics.
Vera Gross, Ph.D., Senior Scientist at PBI. Dr. Gross
presentation, entitled From PCT-HD to SWATH Data Acquisition
in Half a Day, will include a discussion on advances of
quantitative SWATH-MS technology with the introduction of new
PCT-based sample preparation techniques and QC kits from PBI.
Andrew Olson, Vice-President of Business Development at Advaita
Corporation. Mr. Olsen will present an overview of the iPathway
Guide for Next-Gen Proteomics, a cloud-enabled bioinformatics
platform.
An audio recording will be made available after the conference.
Please contact SCIEXs media contact for access (Patrick Farrell,
Sniper Public Relations on behalf of SCIEX, 603-420-8828).
About Pressure BioSciences, Inc.
Pressure BioSciences, Inc. (PBI) (OTCQB:
PBIO) develops, markets, and sells proprietary laboratory
instrumentation and associated consumables to the estimated $6
billion life sciences sample preparation market. Our products are
based on the unique properties of both constant (i.e., static) and
alternating (i.e., pressure cycling technology, or PCT) hydrostatic
pressure. PCT is a patented enabling technology platform that uses
alternating cycles of hydrostatic pressure between ambient and
ultra-high levels to safely and reproducibly control bio-molecular
interactions. To date, we have installed over 260 PCT systems in
approximately 160 sites worldwide. There are over 100 publications
citing the advantages of the PCT platform over competitive methods,
many from key opinion leaders. Our primary application development
and sales efforts are in the biomarker discovery and forensics
areas. Customers also use our products in other areas, such as drug
discovery & design, bio-therapeutics characterization, soil
& plant biology, vaccine development, histology, and forensic
applications.
About SCIEX
SCIEX helps to improve the world we live in by enabling
scientists and laboratory analysts to find answers to the complex
analytical challenges they face. The company's global leadership
and world-class service and support in the capillary
electrophoresis and liquid chromatography-mass spectrometry
industry have made it a trusted partner to thousands of the
scientists and lab analysts worldwide who are focused on basic
research, drug discovery and development, food and environmental
testing, forensics and clinical research.
With over 40 years of proven innovation, SCIEX excels by
listening to and understanding the ever-evolving needs of its
customers to develop reliable, sensitive and intuitive solutions
that continue to redefine what is achievable in routine and complex
analysis. For more information, please visit sciex.com. SCIEX social: Twitter: @SCIEXnews, LinkedIn and Facebook.
About Advaita Bioinformatics
Advaita Bioinformatics is a leader in the development of
analytic solutions for high-throughput biological data. Founded in
2005 with headquarters near Ann Arbor, Michigan, Advaitas novel
analysis helps translate the terabytes of genomic data produced as
a result of gene-expression and protein-expression experiments into
a better understanding of the underlying biological phenomena.
Advaitas patented approach, called Impact Analysis, delivers
results and insights that cannot be achieved with any other
commercial analysis software. iPathwayGuide is the first web
application capable of identifying mechanisms of action,
micro-RNAs, genetic variants, and potential drug targets, directly
from gene-expression experiments. This unique ability helps
researchers quickly zero in on drug targets and validate drug
candidates with the greatest potential for success while avoiding
costly dead-ends. For more information, please visit http://www.AdvaitaBio.com.
Investor Contacts:
Richard T. Schumacher, President & CEO, PBI (508) 230-1828
(T)
Jeffrey N. Peterson, Chairman, PBI (650) 812-8121 (T)
Redwood Investment Group (714) 978-4425 (T)
For more information about PBI and this press release, please
click on the following website link:
http://www.pressurebiosciences.com
Please visit us on Twitter |
LinkedIn | YouTube | Google+
| Facebook